Spotlight Innovation Announces Debt Restructuring Through Conversion of $850,000 in Convertible Promissory Notes

Source:  Spotlight Innovation, Inc.

Spotlight Innovation Inc. (OTCQB: STLT) announced today that the holders of a series of convertible promissory notes issued between December 2015 and March 2016, totaling $850,000, have agreed to convert the promissory notes into shares of Common Stock.

"This conversion is a positive step toward simplifying our balance sheet," said Mr. Cristopher Grunewald, Spotlight Innovation's President and Chief Executive Officer. "Debt restructuring allows us to accelerate development of our product candidates, creating value for both current and future shareholders. Moving forward, we will continue to look for debt restructuring opportunities that further our development goals."

About Spotlight Innovation Inc.

Spotlight Innovation Inc. (OTCQB: STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, we leverage our extensive relationships with leading scientists, academic institutions and other sources. We provide value-added capability to accelerate development progress. When scientifically significant benchmarks have been achieved, we will endeavor to partner with proven market leaders via sale, out-license or strategic alliance. For more information, visit www.spotlightinnovation.com or follow us on www.twitter.com/spotlightinno.